Published in J Biol Chem on July 15, 1987
Compilation of transcription regulating proteins. Nucleic Acids Res (1988) 9.71
A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol Cell Biol (1989) 4.72
Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene. Mol Cell Biol (1989) 3.98
Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci U S A (1996) 3.24
Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol Cell Biol (1991) 2.40
Synergism in ternary complex formation between the dimeric glycoprotein p67SRF, polypeptide p62TCF and the c-fos serum response element. EMBO J (1990) 2.11
Two distinct cellular phosphoproteins bind to the c-fos serum response element. EMBO J (1989) 2.03
Cross-binding of factors to functionally different promoter elements in c-fos and skeletal actin genes. Mol Cell Biol (1989) 1.94
Functional antagonism between YY1 and the serum response factor. Mol Cell Biol (1992) 1.91
Identification of multiple proteins that interact with functional regions of the human cardiac alpha-actin promoter. Mol Cell Biol (1989) 1.82
The upstream muscle-specific enhancer of the rat muscle creatine kinase gene is composed of multiple elements. Mol Cell Biol (1989) 1.73
The CArG promoter sequence is necessary for muscle-specific transcription of the cardiac actin gene in Xenopus embryos. EMBO J (1989) 1.65
Promoter upstream elements of the chicken cardiac myosin light-chain 2-A gene interact with trans-acting regulatory factors for muscle-specific transcription. Mol Cell Biol (1989) 1.63
Detection of two tissue-specific DNA-binding proteins with affinity for sites in the mouse beta-globin intervening sequence 2. Mol Cell Biol (1988) 1.58
Brain and muscle creatine kinase genes contain common TA-rich recognition protein-binding regulatory elements. Mol Cell Biol (1990) 1.55
A common factor regulates skeletal and cardiac alpha-actin gene transcription in muscle. Mol Cell Biol (1988) 1.52
A combination of closely associated positive and negative cis-acting promoter elements regulates transcription of the skeletal alpha-actin gene. Mol Cell Biol (1990) 1.52
Interaction of nuclear proteins with muscle-specific regulatory sequences of the human cardiac alpha-actin promoter. Mol Cell Biol (1988) 1.50
DNA-binding site for two skeletal actin promoter factors is important for expression in muscle cells. Mol Cell Biol (1988) 1.47
Expression of genes encoding the transcription factor SRF during early development of Xenopus laevis: identification of a CArG box-binding activity as SRF. EMBO J (1991) 1.38
CArG boxes in the human cardiac alpha-actin gene are core binding sites for positive trans-acting regulatory factors. Proc Natl Acad Sci U S A (1987) 1.38
Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle. Mol Cell Biol (1993) 1.34
Serum response factor p67SRF is expressed and required during myogenic differentiation of both mouse C2 and rat L6 muscle cell lines. J Cell Biol (1992) 1.30
Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice. Mol Cell Biol (1996) 1.27
A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promoter of the mouse myosin light-chain 1A gene. Mol Cell Biol (1995) 1.23
Identification of single-stranded-DNA-binding proteins that interact with muscle gene elements. Mol Cell Biol (1991) 1.22
The chicken skeletal muscle alpha-actin promoter is tissue specific in transgenic mice. Mol Cell Biol (1989) 1.21
Regulation of the human beta-actin promoter by upstream and intron domains. Nucleic Acids Res (1989) 1.21
Natural and synthetic DNA elements with the CArG motif differ in expression and protein-binding properties. Mol Cell Biol (1991) 1.08
Tissue-specific transcription of the cardiac myosin light-chain 2 gene is regulated by an upstream repressor element. Mol Cell Biol (1991) 1.07
The chicken skeletal alpha-actin gene promoter region exhibits partial dyad symmetry and a capacity to drive bidirectional transcription. Mol Cell Biol (1988) 1.04
Identification of two nuclear factor-binding domains on the chicken cardiac actin promoter: implications for regulation of the gene. Mol Cell Biol (1989) 1.03
Interaction of nuclear proteins with a positive cis-acting element of rat embryonic myosin heavy-chain promoter: identification of a new transcriptional factor. Mol Cell Biol (1989) 0.99
Identification of a 59 bp enhancer located at the first exon/intron boundary of the human O6-methylguanine DNA methyltransferase gene. Nucleic Acids Res (1994) 0.99
Rabbit muscle creatine kinase: genomic cloning, sequencing, and analysis of upstream sequences important for expression in myocytes. Nucleic Acids Res (1991) 0.97
Transcriptional control of the chicken cardiac myosin light-chain gene is mediated by two AT-rich cis-acting DNA elements and binding of serum response factor. Mol Cell Biol (1993) 0.95
Promoter analysis of myosin alkali light chain genes expressed in mouse striated muscle. Nucleic Acids Res (1988) 0.93
The myosin light chain enhancer and the skeletal actin promoter share a binding site for factors involved in muscle-specific gene expression. Mol Cell Biol (1991) 0.92
A single transcription factor binds to two divergent sequence elements with a common function in cardiac myosin light chain-2 promoter. Mol Cell Biol (1992) 0.90
A family of muscle gene promoter element (CArG) binding activities in Xenopus embryos: CArG/SRE discrimination and distribution during myogenesis. Nucleic Acids Res (1991) 0.88
YY1 is the cellular factor shown previously to bind to regulatory regions of several leaky-late (beta gamma, gamma 1) genes of herpes simplex virus type 1. J Virol (1994) 0.87
Involvement of an AFP1-binding site in cell-specific transcription of the pre-S1 region of the human hepatitis B virus surface antigen gene. Nucleic Acids Res (1989) 0.81
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature (1999) 11.37
Nucleotide sequence of yeast LEU2 shows 5'-noncoding region has sequences cognate to leucine. Cell (1982) 6.68
Yeast LEU2. Repression of mRNA levels by leucine and primary structure of the gene product. J Biol Chem (1984) 5.84
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med (2000) 5.72
A simple structural feature is a major determinant of the identity of a transfer RNA. Nature (1988) 5.11
Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation (2000) 4.96
Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest (1998) 4.94
Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel. Science (1992) 4.44
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet (1996) 4.32
Deletion of an essential gene in Escherichia coli by site-specific recombination with linear DNA fragments. J Bacteriol (1984) 4.30
Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation (1998) 4.10
Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science (1999) 4.04
Enzyme structure with two catalytic sites for double-sieve selection of substrate. Science (1998) 3.92
Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem (1999) 3.76
Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol (1996) 3.71
Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol (2001) 3.66
Mapping point mutations in the Drosophila rosy locus using denaturing gradient gel blots. Genetics (1991) 3.66
Aminoacyl tRNA synthetases: general scheme of structure-function relationships in the polypeptides and recognition of transfer RNAs. Annu Rev Biochem (1987) 3.59
Aminoacylation of RNA minihelices with alanine. Nature (1989) 3.42
MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol (1995) 3.32
Transcatheter occlusion of foramen ovale with a button device after neurological decompression illness in professional divers. Lancet (1996) 3.27
Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years. BMJ (2000) 2.73
The branch point effect. Ultrasensitivity and subsensitivity to metabolic control. J Biol Chem (1984) 2.54
Specific sequence homology and three-dimensional structure of an aminoacyl transfer RNA synthetase. Science (1984) 2.52
Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem (1999) 2.46
Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res (2000) 2.39
Enlarging the amino acid set of Escherichia coli by infiltration of the valine coding pathway. Science (2001) 2.35
Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol (2008) 2.30
Dietary calcium, physical activity, and risk of hip fracture: a prospective study. BMJ (1989) 2.24
A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Hum Genet (1992) 2.23
HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J Clin Invest (2001) 2.20
Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot. J Am Coll Cardiol (1991) 2.10
Branch point control by the phosphorylation state of isocitrate dehydrogenase. A quantitative examination of fluxes during a regulatory transition. J Biol Chem (1985) 2.06
Modular arrangement of functional domains along the sequence of an aminoacyl tRNA synthetase. Nature (1984) 2.04
Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science (1996) 2.03
Yeast LEU1. Repression of mRNA levels by leucine and relationship of 5'-noncoding region to that of LEU2. J Biol Chem (1984) 2.01
Specificity for aminoacylation of an RNA helix: an unpaired, exocyclic amino group in the minor groove. Science (1991) 1.96
Aminoacylation error correction. Nature (1996) 1.93
Primary structure of a large aminoacyl-tRNA synthetase. Science (1981) 1.93
FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med (1999) 1.92
Functional antagonism between YY1 and the serum response factor. Mol Cell Biol (1992) 1.91
Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation (1997) 1.91
Determination of flux through the branch point of two metabolic cycles. The tricarboxylic acid cycle and the glyoxylate shunt. J Biol Chem (1984) 1.91
Evidence for dispensable sequences inserted into a nucleotide fold. Science (1987) 1.85
Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol (1999) 1.81
Detection of leucine-independent DNA site occupancy of the yeast Leu3p transcriptional activator in vivo. Mol Cell Biol (1995) 1.79
LEU3 of Saccharomyces cerevisiae encodes a factor for control of RNA levels of a group of leucine-specific genes. Mol Cell Biol (1987) 1.79
Mutational isolation of a sieve for editing in a transfer RNA synthetase. Science (1994) 1.76
Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem (2001) 1.72
LEU3 of Saccharomyces cerevisiae activates multiple genes for branched-chain amino acid biosynthesis by binding to a common decanucleotide core sequence. Mol Cell Biol (1988) 1.72
Characterization of rate-controlling steps in vivo by use of an adjustable expression vector. Proc Natl Acad Sci U S A (1985) 1.69
Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene (1995) 1.67
Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem (2001) 1.65
Functional assembly of a randomly cleaved protein. Proc Natl Acad Sci U S A (1992) 1.65
Understanding structural relationships in proteins of unsolved three-dimensional structure. Proteins (1990) 1.65
A covalent adduct between the uracil ring and the active site of an aminoacyl tRNA synthetase. Nature (1982) 1.65
Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care (1999) 1.65
Overlapping nucleotide determinants for specific aminoacylation of RNA microhelices. Science (1992) 1.64
Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J Biol Chem (2001) 1.64
Enzymatic aminoacylation of an eight-base-pair microhelix with histidine. Proc Natl Acad Sci U S A (1990) 1.63
p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev (1997) 1.63
Structural relationships and the classification of aminoacyl-tRNA synthetases. J Biol Chem (1991) 1.61
Gene for yeast glutamine tRNA synthetase encodes a large amino-terminal extension and provides a strong confirmation of the signature sequence for a group of the aminoacyl-tRNA synthetases. J Biol Chem (1987) 1.59
Aminoacyl-tRNA synthetases: potential markers of genetic code development. Trends Biochem Sci (2001) 1.58
Two classes of tRNA synthetases suggested by sterically compatible dockings on tRNA acceptor stem. Cell (2001) 1.57
Pulse oximetry: a new non-invasive assessment of peripheral arterial occlusive disease. Br J Surg (1990) 1.57
Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation. Circulation (1997) 1.57
Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J Clin Invest (2000) 1.56
An aminoacyl tRNA synthetase binds to a specific DNA sequence and regulates its gene transcription. Nature (1981) 1.55
Primary structure of histidine-tRNA synthetase and characterization of hisS transcripts. J Biol Chem (1985) 1.53
Functional contacts of a transfer RNA synthetase with 2'-hydroxyl groups in the RNA minor groove. Nature (1992) 1.52
Cyclin A downregulation and p21(cip1) upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells. Circ Res (2000) 1.52
Abnormal nonshivering thermogenesis in mice with inherited defects of fatty acid oxidation. J Clin Invest (1998) 1.50
A new troponin T and cDNA clones for 13 different muscle proteins, found by shotgun sequencing. Nature (1983) 1.49
Transfer RNA-dependent translocation of misactivated amino acids to prevent errors in protein synthesis. Mol Cell (1999) 1.48
DNA-binding site for two skeletal actin promoter factors is important for expression in muscle cells. Mol Cell Biol (1988) 1.47
Enzymatic aminoacylation of single-stranded RNA with an RNA cofactor. Proc Natl Acad Sci U S A (1991) 1.46
Sequence determination and modeling of structural motifs for the smallest monomeric aminoacyl-tRNA synthetase. Proc Natl Acad Sci U S A (1991) 1.46
Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation (2001) 1.44
Molecular cloning of a diverged homeobox gene that is rapidly down-regulated during the G0/G1 transition in vascular smooth muscle cells. Mol Cell Biol (1993) 1.44
Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J Biol Chem (2000) 1.42
Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase. J Biol Chem (1999) 1.40
Discrete determinants in transfer RNA for editing and aminoacylation. Science (1997) 1.39
Midazolam infusion in a pediatric intensive care unit. Ann Pharmacother (1993) 1.38
Different regulatory sequences control creatine kinase-M gene expression in directly injected skeletal and cardiac muscle. Mol Cell Biol (1993) 1.38
Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo. J Mol Cell Cardiol (2000) 1.37
Artificially ambiguous genetic code confers growth yield advantage. Proc Natl Acad Sci U S A (2004) 1.36
Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res (1997) 1.35
Enzymatic aminoacylation of sequence-specific RNA minihelices and hybrid duplexes with methionine. Proc Natl Acad Sci U S A (1992) 1.35
TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat Med (1998) 1.34
Human glycyl-tRNA synthetase. Wide divergence of primary structure from bacterial counterpart and species-specific aminoacylation. J Biol Chem (1994) 1.34
Application of a computerized medical decision-making process to the problem of digoxin intoxication. J Am Coll Cardiol (1984) 1.33
Genetic code in evolution: switching species-specific aminoacylation with a peptide transplant. EMBO J (1998) 1.32
Primary structures of both subunits of Escherichia coli glycyl-tRNA synthetase. J Biol Chem (1983) 1.32
Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ Res (2001) 1.31
Relationship between volumes and areas from single transverse scans of intra-abdominal fat measured by magnetic resonance imaging. Int J Obes Relat Metab Disord (1997) 1.30
Evidence for interaction of an aminoacyl transfer RNA synthetase with a region important for the identity of its cognate transfer RNA. J Biol Chem (1988) 1.29
A bacterial amber suppressor in Saccharomyces cerevisiae is selectively recognized by a bacterial aminoacyl-tRNA synthetase. Mol Cell Biol (1990) 1.29
Dispensable pieces of an aminoacyl tRNA synthetase which activate the catalytic site. Cell (1984) 1.28